Reverse Engineering & Solid-State Intelligence in Generic Drug Development Masterclass - US edition

This MasterClass provides a deep-dive into EU sustainable finance and sustainability reporting, focusing on how regulatory requirements such as CSRD and ESRS connect with investor needs and support companies strategic decision-making.

07-08 April, 2026, Virtual
STARTING TIME 08:00 A.M. EDT | 05:00 A.M. PDT | 12:00 UTC

Overview

This MasterClass provides a comprehensive and practice-oriented exploration of reverse engineering and solid-state characterization in generic drug development. Participants will learn how to combine XRPD, DSC/TG, Raman mapping, PSD assessment, SEM/EDS and other techniques to understand reference products, decode formulation strategies, and identify critical quality attributes. Through real case studies and practical interpretation of analytical data, attendees will strengthen their ability to make informed development decisions, anticipate bioequivalence risks, and optimize formulations. The event stands out by merging deep scientific knowledge with real-world R&D experience, offering insights far beyond traditional analytical or formulation training.

#masterclass     #glceurope      #pharmaonlinetraining      #globalleadingconferences       #generic       #reverseengineering     #solidstate    #particleengineering

WHO SHOULD ATTEND

The course will provide practical advice for chemists and pharmacists in the pharmaceutical industry as well as in regulatory agencies.

-R&D scientists
-Formulation specialists
-Analytical development teams
-Solid-state scientists
-Generic development leaders
-Technology Transfer professionals